BRIEF published on 08/10/2026 at 18:34, 34 minutes ago Fuller, Smith & Turner Announces Executive Share Option Grants Market Abuse Regulation Fuller, Smith & Turner PDMR Transactions Executive Share Option Scheme Share Price £7.24
BRIEF published on 08/10/2026 at 18:34, 34 minutes ago Fuller, Smith & Turner annonce l'attribution d'options d'achat d'actions à ses dirigeants Fuller, Smith & Turner Transactions PDMR Réglementation Des Abus De Marché Régime D'options D'achat D'actions Pour Les Cadres Prix De L'action : 7,24 £
PRESS RELEASE published on 08/10/2026 at 18:29, 39 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings Fuller, Smith & Turner PLC announces Director/PDMR Shareholdings under ESOS with options over 40p 'A' Ordinary Shares, based on five day average price of £7.24, vesting on third anniversary of grant PDMR Fuller Smith Turner PLC Director Shareholdings ESOS
PRESS RELEASE published on 08/10/2026 at 18:13, 56 minutes ago MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Secures $10M Strategic Private Placement With Eric Sprott Austin, Texas, August 10th, 2026, FinanceWire
PRESS RELEASE published on 08/10/2026 at 18:11, 58 minutes ago Wrap Technologies (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform Austin, Texas, United States, August 10th, 2026, FinanceWire
PRESS RELEASE published on 08/10/2026 at 18:11, 58 minutes ago Wrap Technologies (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform Austin, Texas, August 10th, 2026, FinanceWire
PRESS RELEASE published on 08/10/2026 at 18:09, 1 hour ago Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2 Austin, Texas, August 10th, 2026, FinanceWire
PRESS RELEASE published on 08/10/2026 at 18:09, 1 hour ago Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2 Austin, Texas, United States, August 10th, 2026, FinanceWire
PRESS RELEASE published on 08/10/2026 at 18:06, 1 hour 2 minutes ago Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial Toronto, Canada, August 10th, 2026, FinanceWire
BRIEF published on 08/10/2026 at 18:05, 1 hour 4 minutes ago AXA Releases Voting Rights and Share Capital Details as of July 2026 Euronext Paris Share Capital Voting Rights AXA Bylaws
Published on 08/10/2026 at 15:30, 3 hours 39 minutes ago Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 3 hours 44 minutes ago Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 4 hours 39 minutes ago NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 5 hours 39 minutes ago Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 6 hours 9 minutes ago Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
Published on 08/10/2026 at 18:29, 39 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 08/10/2026 at 17:50, 1 hour 19 minutes ago Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Published on 08/10/2026 at 17:38, 1 hour 31 minutes ago PATRIZIA delivers strong earnings growth with EUR 42.7m EBITDA (+46.6% y-o-y) in H1 2026
Published on 08/10/2026 at 17:11, 1 hour 58 minutes ago CORRECTION FROM SOURCE: North Peak Commences 2026 Drilling Campaign at Prospect Mountain, Eureka, Nevada
Published on 08/10/2026 at 16:12, 2 hours 57 minutes ago dK Calls on PANDION AG Bondholders to Join Forces
Published on 08/10/2026 at 18:00, 1 hour 9 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 1 hour 9 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 11:53, 7 hours 15 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
![Logo of [UNKNOWN]](https://logos.symex.be/img/.jpg)
